Stockholder Alert: Ademi LLP continues Investigation of the Fairness of Landos Biopharma, Inc.'s transaction with AbbVie
Landos Biopharma, Inc. (LABP)
Company Research
Source: PR Newswire
Impact Snapshot
Event Time:
LABP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LABP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LABP alerts
High impacting Landos Biopharma, Inc. news events
Weekly update
A roundup of the hottest topics
LABP
News
- AbbVie (ABBV) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- SHAREHOLDER ALERT: Weiss Law Investigates Landos Biopharma, Inc.Accesswire
- Landos Biopharma, Inc. (NASDAQ: LABP) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $20.42 price target on the stock, down previously from $50.00.MarketBeat
- LANDOS BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Landos Biopharma, Inc. - LABPBusiness Wire
- SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates LABP, WRK, TGAN, KAMNAccesswire
LABP
Analyst Actions
- 4/1/24 - HC Wainwright
LABP
Sec Filings
- 4/25/24 - Form DEFM14A
- 4/16/24 - Form 10-K/A
- 4/15/24 - Form PREM14A
- LABP's page on the SEC website